Murray TK et al. (2003). LY503430, a novel alpha-amino-3-hydroxy-5-methylisoxazole-4-propionic acid receptor potentiator with functional, neuroprotective and neurotrophic effects in rodent models of Parkinson's disease. The Journal of pharmacology and experimental therapeutics. 306 [PubMed]

See more from authors: Murray TK · Whalley K · Robinson CS · Ward MA · Hicks CA · Lodge D · Vandergriff JL · Baumbarger P · Siuda E · Gates M · Ogden AM · Skolnick P · Zimmerman DM · Nisenbaum ES · Bleakman D · O'Neill MJ

References and models cited by this paper
References and models that cite this paper

Muddapu VR, Mandali A, Chakravarthy VS, Ramaswamy S. (2019). A Computational Model of Loss of Dopaminergic Cells in Parkinson's Disease Due to Glutamate-Induced Excitotoxicity. Frontiers in neural circuits. 13 [PubMed]

This website requires cookies and limited processing of your personal data in order to function. By continuing to browse or otherwise use this site, you are agreeing to this use. See our Privacy policy and how to cite and terms of use.